Overview

Drug utilization analysis plays a critical role in understanding how medicines are prescribed and consumed at scale. Traditional approaches rely heavily on patient-level clinical data and labeled outcomes, which are often unavailable, incomplete, or biased.

This project presents a market-level prescription pattern analysis system that identifies unusual and potentially high-risk drug utilization behavior using unsupervised machine learning. Instead of predicting clinical outcomes, the system focuses on detecting abnormal patterns in drug composition, pricing behavior, and market dynamics.

The primary objective is to support rational drug use studies, regulatory monitoring, and prescription trend analysis through data-driven insights.

Problem Statement

In real-world pharmaceutical markets:

There are no ground-truth labels indicating whether a drug is “safe” or “unsafe” based on utilization.

Prescription behavior is influenced by pricing, competition, availability, and formulation, not just clinical effectiveness.

Supervised learning methods are unsuitable due to the absence of labeled risk outcomes.

This project addresses the problem by modeling normal vs abnormal utilization behavior using unsupervised techniques and statistical deviation analysis.

Key Objectives

Analyze prescription patterns using market-level drug data

Identify anomalous or irregular utilization behavior

Group drugs based on similar utilization characteristics

Generate an interpretable risk score for each drug or composition

Provide visual analytics for research and policy interpretation

Methodology
1. Data Preprocessing

Removal of missing and inconsistent records

Normalization of numerical attributes

Aggregation at the drug composition level

2. Feature Engineering

Features are designed to represent utilization behavior rather than patient outcomes:

Prescription frequency indicators

Market concentration metrics

Pricing and variability statistics

Composition-level market dominance

3. Clustering Analysis

K-Means clustering is used to discover natural groupings in drug utilization patterns.

Clusters represent different market behaviors such as stable, volatile, or dominant drugs.

Clustering is not used for prediction but for structural pattern discovery.

4. Anomaly Detection

Isolation Forest is applied to detect drugs that deviate significantly from typical utilization behavior.

Each drug is assigned a continuous risk score based on its anomaly level.

Higher scores indicate greater deviation from normal market behavior.

5. Visualization and Interpretation

Cluster distribution plots

Risk score vs market composition analysis

Identification of top anomalous drugs

Statistical summaries of detected patterns

Why Unsupervised Learning?

No labeled outcomes exist for prescription risk at the market level

Utilization anomalies are context-dependent

Unsupervised methods allow detection of previously unknown patterns

Results are more suitable for exploratory and regulatory analysis

Technologies Used

Python

Pandas, NumPy

Scikit-learn

Matplotlib / Seaborn

Jupyter / Google Colab

Project Structure
├── data/
│   ├── raw/
│   └── processed/
├── notebooks/
│   ├── data_preprocessing.ipynb
│   ├── clustering_analysis.ipynb
│   └── anomaly_detection.ipynb
├── src/
│   ├── feature_engineering.py
│   ├── clustering.py
│   └── risk_scoring.py
├── results/
│   ├── figures/
│   └── reports/
└── README.md

Outputs

Drug-wise utilization clusters

Continuous risk scores for each drug composition

Visual insights into prescription and market behavior

Reproducible analysis pipeline

Limitations

The system does not use patient-level clinical data

Risk scores represent statistical anomalies, not medical safety conclusions

Results should be interpreted in conjunction with domain expertise

Future Work

Integration of temporal analysis for trend evolution

Inclusion of guideline-based drug references

Expansion to multi-country or multi-market datasets

Explainability extensions using SHAP or feature attribution

Disclaimer

This project is intended for academic and research purposes only.
It does not provide medical advice, clinical recommendations, or diagnostic decisions.

Author

Arpit Yadav
B.Tech Computer Science
Lovely Professional University
